What amount sold does Strategic Pharmaceutical Solutions Inc report in Form D filings?

The latest linked filings report $23.3M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Strategic Pharmaceutical Solutions Inc's most recent SEC filing?

Strategic Pharmaceutical Solutions Inc's most recent Form D filing was on 2018-03-15.

How many investors does Strategic Pharmaceutical Solutions Inc have?

The most recent Form D filing lists 2 investor(s).

What type of securities does Strategic Pharmaceutical Solutions Inc offer?

Strategic Pharmaceutical Solutions Inc's SEC Form D filings indicate debt offerings.

Strategic Pharmaceutical Solutions Inc

CIK: 0001365077·Other Technology·Portland, OR·Corporation

Reported Sold

$23,339,080

Total Filings

Identified Offerings

Last Filed

Mar 15, 2018

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other industry

SEC EDGAR

Offering filing timeline

Mar 15, 2018Form D — New notice

Reported sold: $1,492,758 · Target: $3,000,000

Rule 506(b)·2 investors

May 31, 2016Form D — New notice

Reported sold: $1,870,738 · Target: $1,870,738

Rule 506(b)·1 investor

Oct 29, 2015Form D — New notice

Reported sold: $9,975,584 · Target: $12,185,584

Rule 506(b)·1 investor

Apr 20, 2010Form D — New notice

Reported sold: $10,000,000 · Target: $20,000,000

Rule 506·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 4 identified offerings

$23,339,080

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Greg Colvin

Related Person

Appears on 4 filings

Bob Antin

Related Person

Appears on 4 filings

George Henriques

Related Person

Appears on 3 filings

Kurt Green

Related Person

Appears on 3 filings

Doug Drew

Related Person

Appears on 3 filings

Jim Cleary

Related Person

Appears on 3 filings

Scott Anderson

Related Person

Appears on 2 filings

Steve Fisher

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 15, 2018	New	$3,000,000	$1,492,758	2
May 31, 2016	New	$1,870,738	$1,870,738	1
Oct 29, 2015	New	$12,185,584	$9,975,584	1
Apr 20, 2010	New	$20,000,000	$10,000,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Araceli Biosciences Inc.

Other Technology

Offering target: $4,500,000

Filed Nov 3, 2026